Taro Pharmaceutical
TARO
#4537
Rank
$1.58 B
Marketcap
$42.30
Share price
0.24%
Change (1 day)
46.67%
Change (1 year)

P/E ratio for Taro Pharmaceutical (TARO)

P/E ratio as of May 2024 (TTM): 69.2

According to Taro Pharmaceutical's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 69.1803. At the end of 2021 the company had a P/E ratio of > 1000.

P/E ratio history for Taro Pharmaceutical from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2021> 1000-13596.67%
2020-9.28-168.19%
201913.626.72%
201810.7-47.17%
201720.3125.78%
20169.01-21.34%
201511.4-23.83%
201415.08.81%
201313.868.39%
20128.2014.01%
20117.20-26.01%
20109.72218.69%
20093.05
2005466406.31%
200492.0202.3%
200330.426.23%
200224.1-32.43%
200135.7

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
11.0-84.17%๐Ÿ‡บ๐Ÿ‡ธ USA
27.5-60.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
15.5-77.52%๐Ÿ‡บ๐Ÿ‡ธ USA
71.8 3.85%๐Ÿ‡บ๐Ÿ‡ธ USA
12.8-81.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
-8.15-111.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.